Business
Biocon reported a 51% decline in net profit to Rs 41 crore for the second quarter. While revenue grew by 2% year-on-year, the company's overall performance fell short of market expectations. These results highlight significant pressure on the firm's profitability as it struggles to meet analyst estimates across all key financial fronts.
Short2News gives you the day's news as fast 60-word cards, in your own language.
US Midterm Election Results May Influence Trade Talks With India
Should You Use Your EPF Money To Repay Your Home Loan?
Alembic Pharma Stock Hits Upper Circuit After Q2 Profit Surges 81%
Lord's Mark Industries CEO Dr. Sachidanand Upadhyay Featured in TIME Magazine
Tesla and SpaceX Shares Dip Following US Election Results
Open in Short2NewsFree · Telugu, Hindi & more
Open